Invitrogen™ Human CD263 (TRAIL-R3) Synthetic Peptide

Catalog No.	Quantity
PEP0084	50 μg

Catalog No. PEP0084 Supplier Invitrogen™ Supplier No. PEP0084

Description

Synthetic Peptide

DcR1 Synthetic Peptide, PEP-0084, from Invitrogen.

TRAIL-R3 (CD263) is a member of the TNF-receptor superfamily. This receptor contains an extracellular TRAIL-binding domain and a transmembrane domain, but no cytoplasmic death domain. This receptor is not capable of inducing apoptosis, and is thought to function as an antagonistic receptor that protects cells from TRAIL-induced apoptosis. This gene was found to be a p53-regulated DNA damage-inducible gene. The expression of this gene was detected in many normal tissues but not in most cancer cell lines, which may explain the specific sensitivity of cancer cells to the apoptosis-inducing activity of TRAIL.

Specifications

• Gene ID (Entrez): 8794
• Species: Human
• Purification Method: purified
• Accession Number: O14798
• Common Name: Human CD263 (TRAIL-R3)
• Concentration: 200 μg/mL
• Content And Storage: -20°C
• Description: Synthetic Peptide
• Format: Liquid
• Formulation: PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
• For Use With (Application): Blocking Assay, Control
• Gene Symbol: TNFRSF10C
• Lyophilized: No
• Preservative: 0.02% sodium azide
• Product Type: Peptide
• Quantity: 50 μg
• Regulatory Status: RUO - research use only
• Storage Buffer: PBS